CLL/SLL First-Line Treatments and Second Cancers. What Recent Research Shows
A common concern for people living with CLL/SLL is whether treatment increases the risk of developing another cancer. Recent research offers reassuring news.
What Canadian Experts Are Saying About First-Line, Time-Limited CLL Treatment
What do Canadian hematologists see as the biggest opportunities—and challenges—of time-limited treatment for CLL in previously untreated patients?